The Global Preventive Vaccines Market is steadily expanding as healthcare systems worldwide prioritize disease prevention and immunization programs. According to industry insights, the market is expected to register a CAGR of 4.7% during the forecast period from 2025 to 2031, reflecting consistent growth driven by rising awareness of preventive healthcare and increasing global vaccination...
According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030.
Meningococcal polysaccharide vaccines are immunogenic preparations...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek